Back to Search
OLENKA CAFFO, MD
MD
Family Medicine Physician
NPI: 1316575574IndividualAccepts Medicare
Specialties, Licenses & Credentials
Education
FLORIDA STATE UNIVERSITY COLLEGE OF MEDICINE
Class of 2020
Research & Publications (20)
Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer.
PMID 19632738·Lung Cancer·2010
8-other
Development and daily use of an electronic oncological patient record for the total management of cancer patients: 7 years' experience.
PMID 18718889·Ann Oncol·2009
8-other
Docetaxel, with or without estramustine phosphate, as first-line chemotherapy for hormone-refractory prostate cancer: results of a multicentre, randomized phase II trial.
PMID 18485028·BJU Int·2008
3-trial
Simultaneous determination of gemcitabine and its main metabolite, dFdU, in plasma of patients with advanced non-small-cell lung cancer by high-performance liquid chromatography-tandem mass spectrometry.
PMID 17941128·J Mass Spectrom·2008
3-trial
Single-agent pemetrexed or sequential pemetrexed/gemcitabine as front-line treatment of advanced non-small cell lung cancer in elderly patients or patients ineligible for platinum-based chemotherapy: a multicenter, randomized, phase II trial.
PMID 17410045·J Thorac Oncol·2007
3-trial
Prospective evaluation of quality of life after interstitial brachytherapy for localized prostate cancer.
PMID 16765529·Int J Radiat Oncol Biol Phys·2006
8-other
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study.
PMID 16192578·J Clin Oncol·2005
4-observational
A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study.
PMID 15558071·Br J Cancer·2004
3-trial
Phase I study of gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer.
PMID 14630267·Int J Radiat Oncol Biol Phys·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 150 PARK ST
LAWRENCE, MA 01841 - Phone
- (978) 685-1770
Quick Facts
- NPI
- 1316575574
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 2
- Years in Practice
- 6
- Publications
- 20
Are you this provider?
Claim Your Profile